Transplantation of Ovarian Cortex to Restore Fertility (ovatrspl)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2011 by Hadassah Medical Organization
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT01442584
First received: July 13, 2011
Last updated: September 27, 2011
Last verified: July 2011
  Purpose

Ovarian transplantation has been shown to restore fertility.


Condition Intervention
Pregnancy
Procedure: ovarian transplantation

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Official Title: Transplantation of Ovarian Cortex to Restore Fertility

Further study details as provided by Hadassah Medical Organization:

Primary Outcome Measures:
  • pregnancy [ Time Frame: 3-6 months ] [ Designated as safety issue: Yes ]
    we will start IVF within 3 months


Estimated Enrollment: 5
Study Start Date: July 2011
Estimated Study Completion Date: January 2016
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: fertility restoration by transplantation
fertility restoration by transplantation of ovarian cortex slivers that were cryopreserved prior to chemotherapy
Procedure: ovarian transplantation
ovarian transplantation
Other Name: frozen thawed ovarian cortex transplantation

Detailed Description:

The investigators transplant ovarian cortex previously collected from the patient prior to cancer treatment.

  Eligibility

Ages Eligible for Study:   20 Years to 54 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients who froze ovarian tissue

Exclusion Criteria:

  • malignant cells in ovary
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01442584

Contacts
Contact: ariel revel, md 97226777111 ext 74399 arielr2@hadassah.org.il

Locations
Israel
Hadassah Recruiting
Jerusalem, Israel
Contact: ariel revel, md    97226777111 ext 74399    arielr2@hadassah.org.il   
Principal Investigator: ariel revel, md         
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Study Chair: Ariel Revel, MD Hadassah
  More Information

No publications provided

Responsible Party: hadassah, Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT01442584     History of Changes
Other Study ID Numbers: ovarian transplant- HMO-CTIL
Study First Received: July 13, 2011
Last Updated: September 27, 2011
Health Authority: Israel: Ministry of Health

Keywords provided by Hadassah Medical Organization:
ovary
cortex
transplantation

ClinicalTrials.gov processed this record on October 20, 2014